Studies in AD mouse models and cell culture reveal that pTau induces RIPK1/RIPK3/MLKL activation and concurrently stimulates NF-κB-driven pro-inflammatory cytokine production, which further amplifies microglial activation and neuronal damage (Zhang et al. 2023). Here, RIPK1 is linked to Alzheimer disease.